BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3101040)

  • 1. The dynamics of chromatin carcinogen interactions in the human cell.
    Kootstra A
    Nucleic Acids Res; 1986 Dec; 14(24):9897-909. PubMed ID: 3101040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of benzo[alpha]pyrene diol-epoxide with nuclei and isolated chromatin.
    Kootstra A; Slaga TJ; Olins DE
    Chem Biol Interact; 1979 Dec; 28(2-3):225-36. PubMed ID: 121556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of an ultimate carcinogen, benzo[a]pyrene diol epoxide, with nucleosomal core particles: apparent lack of protection of DNA by histone proteins.
    MacLeod MC; Smith B; Lew LK
    Mol Carcinog; 1989; 1(4):245-52. PubMed ID: 2506886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzo[alpha]pyrene diol epoxide I binds to DNA at replication forks.
    Paules RS; Cordeiro-Stone M; Mass MJ; Poirier MC; Yuspa SH; Kaufman DG
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2176-80. PubMed ID: 3127827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxide after injection of benzo(a)pyrene or the diol-epoxide.
    Ginsberg GL; Atherholt TB
    Cancer Res; 1990 Feb; 50(4):1189-94. PubMed ID: 2105163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA-carcinogen interaction: covalent DNA-adducts of benzo(a)pyrene 7,8-dihydrodiol 9,10-epoxides studied by biochemical and biophysical techniques.
    Gräslund A; Jernström B
    Q Rev Biophys; 1989 Feb; 22(1):1-37. PubMed ID: 2501820
    [No Abstract]   [Full Text] [Related]  

  • 7. The importance of intercalation in the covalent binding of benzo(a)pyrene diol epoxide to DNA.
    Macleod MC
    J Theor Biol; 1990 Jan; 142(1):113-22. PubMed ID: 2112670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential removal of DNA adducts derived from anti-diol epoxides of dibenzo[a,l]pyrene and benzo[a]pyrene in human cells.
    Dreij K; Seidel A; Jernström B
    Chem Res Toxicol; 2005 Apr; 18(4):655-64. PubMed ID: 15833025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical localization of benzo(a)pyrene-DNA adducts in human tissue.
    Shamsuddin AK; Gan R
    Hum Pathol; 1988 Mar; 19(3):309-15. PubMed ID: 3126127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A-DNA accommodates adducts derived from diol epoxides of polycyclic aromatic hydrocarbons bound in a "side-stacking" mode.
    Andersen RW; Whitlow MD; Teeter MM; Mohr SC
    J Biomol Struct Dyn; 1987 Oct; 5(2):383-404. PubMed ID: 3152156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence specificity in the reaction of benzopyrene diol epoxide with DNA.
    Osborne MR
    Chem Biol Interact; 1990; 75(2):131-40. PubMed ID: 2114949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential binding of the carcinogen benzo[a]pyrene to DNA in active chromatin and the nuclear matrix.
    Obi FO; Ryan AJ; Billett MA
    Carcinogenesis; 1986 Jun; 7(6):907-13. PubMed ID: 3085969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of a reactive, electrophilic carcinogen, benzo[a]pyrene diol epoxide, by mammalian cells.
    MacLeod MC; Adair G; Dickson-Black D; Pevny T; Humphrey RM
    Chem Biol Interact; 1987; 63(3):279-89. PubMed ID: 3119238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential binding of the carcinogen benzo[a]pyrene to proteins of the nuclear matrix.
    Obi FO; Billett MA
    Carcinogenesis; 1991 Mar; 12(3):481-6. PubMed ID: 2009593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of histone acetylation on the formation and removal of B(a)P chromatin adducts.
    Kootstra A
    Nucleic Acids Res; 1982 May; 10(9):2775-89. PubMed ID: 6285308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of benzo[a]pyrene-diol-epoxide binding to histone H2A with different carboxy-terminal regions.
    Kurokawa M; MacLeod MC
    Carcinogenesis; 1988 Mar; 9(3):419-25. PubMed ID: 3125994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloperoxidase-enhanced formation of (+-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene-DNA adducts in lung tissue in vitro: a role of pulmonary inflammation in the bioactivation of a procarcinogen.
    Petruska JM; Mosebrook DR; Jakab GJ; Trush MA
    Carcinogenesis; 1992 Jul; 13(7):1075-81. PubMed ID: 1322250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of (+)-trans-benzo[a]pyrene-7,8-dihydrodiol by 3-methylcholanthrene-induced rat liver homogenates.
    Sindhu RK; Kikkawa Y
    Toxicol Lett; 1995 Nov; 81(1):5-13. PubMed ID: 8525499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of a carcinogen to the nucleosomal and non-nucleosomal regions of the simian virus 40 chromosome in vivo.
    Seidman M; Slor H; Bustin M
    J Biol Chem; 1983 Apr; 258(8):5215-20. PubMed ID: 6300121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons.
    Shimada T; Martin MV; Pruess-Schwartz D; Marnett LJ; Guengerich FP
    Cancer Res; 1989 Nov; 49(22):6304-12. PubMed ID: 2509067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.